V019-3895 Screening compound: N-[1-(3,4-dimethoxyphenyl)-4-phenyl-1H-imidazol-2-yl]-2-{N-[2-(morpholin-4-yl)ethyl]-2-phenylacetamido}acetamide

V019-3895 Screening compound: N-[1-(3,4-dimethoxyphenyl)-4-phenyl-1H-imidazol-2-yl]-2-{N-[2-(morpholin-4-yl)ethyl]-2-phenylacetamido}acetamide
V019-3895 Screening compound: N-[1-(3,4-dimethoxyphenyl)-4-phenyl-1H-imidazol-2-yl]-2-{N-[2-(morpholin-4-yl)ethyl]-2-phenylacetamido}acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V019-3895
N-[1-(3,4-dimethoxyphenyl)-4-phenyl-1H-imidazol-2-yl]-2-{N-[2-(morpholin-4-yl)ethyl]-2-phenylacetamido}acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V019-3895

Molecular Formula

C33H37N5O5 (C33 H37 N5 O5)

Compound Name

N-[1-(3,4-dimethoxyphenyl)-4-phenyl-1H-imidazol-2-yl]-2-{N-[2-(morpholin-4-yl)ethyl]-2-phenylacetamido}acetamide

IUPAC name

N-[1-(34-dimethoxyphenyl)-4-phenyl-1H-imidazol-2-yl]-2-{N-[2-(morpholin-4-yl)ethyl]-2-phenylacetamido}acetamide

SMILES

COc(ccc(-n1c(NC(CN(CCN2CCOCC2)C(Cc2ccccc2)=O)=O)nc(-c2ccccc2)c1)c1)c1OC

InChI

InChI=1S/C33H37N5O5/c1-41-29-14-13-27(22-30(29)42-2)38-23-28(26-11-7-4-8-12-26)34-33(38)35-31(39)24-37(16-15-36-17-19-43-20-18-36)32(40)21-25-9-5-3-6-10-25/h3-14,22-23H,15-21,24H2,1-2H3,(H,34,35,39)

InChI Key

GBTDUNGWECMMQO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19821988

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

583.69

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

14.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

4.011

Distribution Coefficient, logD

3.981

Water Solubility, LogSw

-4.03

Polar Surface Area

78.996

Acid Dissociation Constant (pKa)

13.17

Base Dissociation Constant (pKb)

6.26

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

30.30

V019-3895 in Drug Discovery

Included in Screening Libraries

MCL1 Targeted Library (12200 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with V019-3895 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V019-3895?
Check Price and Availability of V019-3895, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V019-3895 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V019-3895
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V019-3895
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V019-3895 available by request